|
1
|
Mämmelä P, Savolainen H, Lindroos L,
Kangas J and Vartiainen T: Analysis of oak tannins by liquid
chromatography-electrospray ionisation mass spectrometry. J
Chromatogr A. 891:75–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nierenstein M: The formation of ellagic
acid from galloyl-glycine by penicillium. Biochem J. 9:240–244.
1915. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakai S: Myriophyllum
spicatum-released allelopathic polyphenols inhibiting growth of
blue-green algae Microcystis aeruginosa. Water Res.
34:3026–3032. 2000. View Article : Google Scholar
|
|
4
|
Prasad KN, Yang B, Yang S, Chen Y, Zhao M,
Ashraf M and Jiang Y: Identification of phenolic compounds and
appraisal of antioxidant and antityrosinase activities from litchi
(Litchi sinensis Sonn.) seeds. Food Chem. 116:1–7. 2009.
View Article : Google Scholar
|
|
5
|
Estela de Rezende Q, Patto de Abreu CM,
Kelly da Silva O, Vinicius de Oliveira R and Fráguas RM: Bioactive
phytochemicals and antioxidant activity in fresh and dried lychee
fractions. Rev Ciênc Agron. 46:163–169. 2015. View Article : Google Scholar
|
|
6
|
Soong YY and Barlow PJ: Isolation and
structure elucidation of phenolic compounds from longan
(Dimocarpus longan Lour.) seed by high-performance liquid
chromatography-electrospray ionization mass spectrometry. J
Chromatogr A. 1085:270–277. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng G, Xu L, Wu P, Xie H, Jiang Y, Chen
F and Wei X: Polyphenols from longan seeds and their
radical-scavenging activity. Food Chem. 116:433–436. 2009.
View Article : Google Scholar
|
|
8
|
Rangkadilok N, Sitthimonchai S,
Worasuttayangkurn L, Mahidol C, Ruchirawat M and Satayavivad J:
Evaluation of free radical scavenging and antityrosinase activities
of standardized longan fruit extract. Food Chem Toxicol.
45:328–336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tseng HC, Wu WT, Huang HS and Wu MC:
Antimicrobial activities of various fractions of longan
(Dimocarpus longan Lour. Fen Ke) seed extract. Int J Food
Sci Nutr. 65:589–593. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vattem DA and Shetty K: Biological
function of ellagic acid: A review. J Food Biochem. 29:234–266.
2005. View Article : Google Scholar
|
|
11
|
Usta C, Ozdemir S, Schiariti M and Puddu
PE: The pharmacological use of ellagic acid-rich pomegranate fruit.
Int J Food Sci Nutr. 64:907–913. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Infante R, Contador L, Rubio P, Aros D and
Peña-Neira Á: Postharvest sensory and phenolic characterization of
‘Elegant Lady’ and ‘Carson’ peaches. Chil J Agric Res. 71:445–451.
2011. View Article : Google Scholar
|
|
13
|
Seeram NP, Adams LS, Henning SM, Niu Y,
Zhang Y, Nair MG and Heber D: In vitro antiproliferative, apoptotic
and antioxidant activities of punicalagin, ellagic acid and a total
pomegranate tannin extract are enhanced in combination with other
polyphenols as found in pomegranate juice. J Nutr Biochem.
16:360–367. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vattem DA and Shetty K: Biological
function of ellagic acid: A Review. J Food Biochem. 29:234–266.
2005. View Article : Google Scholar
|
|
15
|
Emanuele S, Lauricella M, Calvaruso G,
D'Anneo A and Giuliano M: Litchi chinensis as a functional
food and a source of antitumor compounds: An overview and a
description of biochemical pathways. Nutrients. 9:E9922017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Narayanan BA, Geoffroy O, Willingham MC,
Re GG and Nixon DW: p53/p21(WAF1/CIP1) expression and its possible
role in G1 arrest and apoptosis in ellagic acid treated cancer
cells. Cancer Lett. 136:215–221. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mandal S, Shivapurkar NM, Galati AJ and
Stoner GD: Inhibition of N-nitrosobenzylmethylamine metabolism and
DNA binding in cultured rat esophagus by ellagic acid.
Carcinogenesis. 9:1313–1316. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mandal S and Stoner GD: Inhibition of
N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats
by ellagic acid. Carcinogenesis. 11:55–61. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Teel RW, Babcock MS, Dixit R and Stoner
GD: Ellagic acid toxicity and interaction with benzo[a]pyrene and
benzo[a]pyrene 7,8-dihydrodiol in human bronchial epithelial cells.
Cell Biol Toxicol. 2:53–62. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Casewatch, . https://www.casewatch.net/fdawarning/prod/2008/best_on_earth.shtmlDecember
2–2018
|
|
21
|
Marnett LJ: Cyclooxygenase mechanisms.
Curr Opin Chem Biol. 4:545–552. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Williams CS, Mann M and DuBois RN: The
role of cyclooxygenases in inflammation, cancer, and development.
Oncogene. 18:7908–7916. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fitzpatrick FA: Cyclooxygenase enzymes:
Regulation and function. Curr Pharm Des. 10:577–588. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mitchell JA and Kirkby NS: Eicosanoids,
prostacyclin and cyclooxygenase in the cardiovascular system. Br J
Pharmacol. Feb 21–2018.(Epub ahead of print).
|
|
25
|
Duggan KC, Walters MJ, Musee J, Harp JM,
Kiefer JR, Oates JA and Marnett LJ: Molecular basis for
cyclooxygenase inhibition by the non-steroidal anti-inflammatory
drug naproxen. J Biol Chem. 285:34950–34959. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blobaum AL and Marnett LJ: Structural and
functional basis of cyclooxygenase inhibition. J Med Chem.
50:1425–1441. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Marnett LJ, Rowlinson SW, Goodwin DC,
Kalgutkar AS and Lanzo CA: Arachidonic acid oxygenation by COX-1
and COX-2. Mechanisms of catalysis and inhibition. J Biol Chem.
274:22903–22906. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kurumbail RG, Kiefer JR and Marnett LJ:
Cyclooxygenase enzymes: Catalysis and inhibition. Curr Opin Struct
Biol. 11:752–760. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bai HW and Zhu BT: Strong activation of
cyclooxygenase I and II catalytic activity by dietary
bioflavonoids. J Lipid Res. 49:2557–2570. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bai HW and Zhu BT: Myricetin and quercetin
are naturally occurring co-substrates of cyclooxygenases in vivo.
Prostaglandins Leukot Essent Fatty Acids. 82:45–50. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang P, Bai HW and Zhu BT: Structural
basis for certain naturally occurring bioflavonoids to function as
reducing co-substrates of cyclooxygenase I and II. PloS One 2010,.
5:e123162010. View Article : Google Scholar
|
|
32
|
Gupta K, Selinsky BS, Kaub CJ, Katz AK and
Loll PJ: The 2.0 Å resolution crystal structure of prostaglandin
H2 synthase-1: Structural insights into an unusual
peroxidase. J Mol Biol. 335:503–518. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duggan KC, Walters MJ, Musee J, Harp JM,
Kiefer JR, Oates JA and Marnett LM: Molecular basis for
cyclooxygenase inhibition by the non-steroidal anti-inflammatory
drug naproxen. J Biol Chem. 285:34950–34959. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Im W, Lee MS and Brooks CL III:
Generalized born model with a simple smoothing function. J Comput
Chem. 24:1691–1702. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Uciechowska U, Schemies J, Scharfe M,
Lawson M, Wichapong K, Jung M and Sippl W: Binding free energy
calculations and biological testing of novel thiobarbiturates as
inhibitors of the human NAD+ dependent histone
deacetylase Sirt2. Med Chem Comm. 3:167–173. 2012. View Article : Google Scholar
|
|
36
|
Pouplana R, Lozano JJ and Ruiz J:
Molecular modelling of the differential interaction between several
non-steroidal anti-inflammatory drugs and human prostaglandin
endoperoxide H synthase-2 (h-PGHS-2). J Mol Graph Model.
20:329–343. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu BT, Bai HW, Rao S and Sui HC: Galangin
inhibits cyclooxygenase by blocking the function of the reducing
cosubstrate at the peroxidase site. FASEB J. submitted. 2018.
|
|
38
|
Sui HC and Zhu BT: Catalytic mechanism of
the peroxidase activity of human cyclooxygenase and the role of
phenol as a reducing co-substrate. Sci Rep. submitted. 2018.
|
|
39
|
Anslyn EV and Dougherty DA: Modern
Physical Organic Chemistry. University Science; Sausalito, CA:
2004
|
|
40
|
Chen H: The production and uses of litchis
in China. http://ir4.rutgers.edu/GMUS/presentation%20pdf/day1Chen.pdfApril.
2018
|
|
41
|
Menzel CM and Waite GK: Litchi and Longan.
Botany, Production and Uses. CABI Publishing; Wallingford, UK:
2005
|
|
42
|
Spencer PS and Palmer VS: The enigma of
litchi toxicity: An emerging health concern in southern Asia.
Lancet Glob Health. 5:e383–e384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Paireau J, Tuan NH, Lefrançois R,
Buckwalter MR, Nghia ND, Hien NT, Lortholary O, Poirée S,
Manuguerra JC, Gessain A, et al: Litchi-associated acute
encephalitis in children, Northern Vietnam, 2004–2009. Emerg Infect
Dis. 18:1817–1824. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shrivastava A, Kumar A, Thomas JD,
Laserson KF, Bhushan G, Carter MD, Chhabra M, Mittal V, Khare S,
Sejvar JJ, et al: Association of acute toxic encephalopathy with
litchi consumption in an outbreak in Muzaffarpur, India, 2014: A
case-control study. Lancet Glob Health. 5:e458–e466. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Islam MS, Sharif AR, Sazzad HMS, Khan
AKMD, Hasan M, Akter S, Rahman M, Luby SP, Heffelfinger JD and
Gurley ES: Outbreak of sudden death with acute encephalitis
syndrome among children associated with exposure to lychee orchards
in Northern Bangladesh, 2012. Am J Trop Med Hyg. 97:949–957. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Krumholz HM, Ross JS, Presler AH and
Egilman DS: What have we learnt from Vioxx? BMJ. 334:120–123. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
McGettigan P and Henry D: Cardiovascular
risk and inhibition of cyclooxygenase: A systematic review of the
observational studies of selective and nonselective inhibitors of
cyclooxygenase 2. JAMA. 296:1633–1644. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
White WB: Cardiovascular risk,
hypertension, and NSAIDs. Curr Rheumatol Rep. 9:36–43. 2007.
View Article : Google Scholar : PubMed/NCBI
|
